Lung cancer often is diagnosed in the advanced stages. Because of the seriousness of the disease, it is important to turn to clinical experts with training and expertise in treating not just cancer, but lung cancer specifically. New treatments are constantly being developed in this era of precision, genomic-based cancer care, so finding a treatment plan that includes available innovations tailored to your tumor type, stage, genomic markers and other needs may be key to finding a treatment option that is best for you.
At Cancer Treatment Centers of America® (CTCA), Phoenix, our focus on lung cancer enables our oncologists to stay up to date on new and emerging treatments and technologies, helping you make informed decisions about the options available to treat the disease and manage its side effects. Your team of lung cancer experts collaborate daily, all under one roof, conferring with you and one another to develop a detailed treatment plan more quickly and efficiently. As part of our commitment to providing state-of-the-art lung cancer treatment options, we offer qualifying patients an opportunity to participate in ongoing clinical trials in immunotherapy, and other areas of innovation. Our Lung Cancer Center team will help you determine whether you are a candidate for an available study and, if so, help you enroll.